Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV

WHO moves closer to making breast cancer treatment affordable to women globally

by

GENEVA Dec 27, 2019 - 11:52 am GMT+3
The cheaper medicines are produced from biological sources such as cells rather than synthesised chemicals. (Reuters Photo)
The cheaper medicines are produced from biological sources such as cells rather than synthesised chemicals. (Reuters Photo)
by Dec 27, 2019 11:52 am

The World Health Organization (WHO) announced Wednesday that it had for the first time approved a "biosimilar" medicine – one derived from living sources rather than chemicals – to make breast cancer treatment affordable to women globally.

The Trastuzumab drug has shown "high efficacy" in curing early-stage breast cancer and in some cases more advanced forms of the disease, the WHO said in a statement.

But the annual cost of the original drug is an average $20,000, "a price that puts it out of reach of many women and health care systems in most countries," the statement added.

However, the biosimilar version of Trastuzumab is generally 65% cheaper than the original.

"With this WHO listing, and more products expected in the prequalification pipeline, prices should decrease even further," the WHO said.

The cheaper, but equally effective biotherapeutic medicines are produced from biological sources such as cells rather than synthesized chemicals.

They are usually manufactured by companies after the patent on the original product has expired.

"WHO prequalification of biosimilar Trastuzumab is good news for women everywhere," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus.

"Women in many cultures suffer from gender disparity when it comes to accessing health services. In poor countries, there is the added burden of a lack of access to treatment for many, and the high cost of medicine.

"Effective, affordable breast cancer treatment should be a right for all women, not the privilege of a few, " he added.

A few biosimilars of Trastuzumab have come on the market in recent years, but none had previously been prequalified by WHO.

WHO prequalification gives countries the assurance that they are purchasing "quality health products."

"We need to act now and try to avoid more preventable deaths," said Dr. Mariangela Simao, WHO assistant director-general for Medicines and Health Products.

"The availability of biosimilars has decreased prices, making even innovative treatments more affordable and hopefully available to more people."

  • shortlink copied
  • RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    homepage
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    No Image
    Wildfires rage worldwide amid climate crisis
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021